Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Kumegawa K"'
Autor:
Sakimoto Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Matsui S; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Yamaguchi T; Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Mukai T; Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Okabayashi K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Mori S; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Akiyoshi T; Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.
Publikováno v:
BJC reports [BJC Rep] 2024 Nov 18; Vol. 2 (1), pp. 88. Date of Electronic Publication: 2024 Nov 18.
Autor:
Otsuji K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Takahashi Y; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Osako T; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Kobayashi T; Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Takano T; Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Saeki S; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Yang L; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Baba S; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Noda T; Director's room, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Ohno S; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Ueno T; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 Oct 03; Vol. 8 (1), pp. 222. Date of Electronic Publication: 2024 Oct 03.
Autor:
Shiraishi R; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Cancila G; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Torrejon J; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Basili I; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Bernardi F; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Silva PBGD; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg 69120, Germany., Wang W; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Chapman O; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Yang L; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Jami M; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Nishitani K; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Arai Y; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Xiao Z; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Yu H; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Lo Re V; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Marsaud V; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Talbot J; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France., Lombard B; Institut Curie, PSL Research University, CurieCoreTech Mass Spectrometry Proteomics, Paris 75005, France., Loew D; Institut Curie, PSL Research University, CurieCoreTech Mass Spectrometry Proteomics, Paris 75005, France., Jingu M; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan; Department of Biomolecular Science, Graduate School of Science, Toho University, Chiba 274-8510, Japan., Okonechnikov K; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg 69120, Germany., Sone M; Department of Biomolecular Science, Graduate School of Science, Toho University, Chiba 274-8510, Japan., Motohashi N; Department of Molecular Therapy, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Aoki Y; Department of Molecular Therapy, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg 69120, Germany., Chavez L; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA., Hoshino M; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan., Maruyama R; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. Electronic address: reo.maruyama@jfcr.or.jp., Ayrault O; Institut Curie, PSL Research University, CNRS UMR, INSERM, Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay 91400, France. Electronic address: olivier.ayrault@curie.fr., Kawauchi D; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8502, Japan. Electronic address: kawauchi@med.nagoya-cu.ac.jp.
Publikováno v:
Developmental cell [Dev Cell] 2024 Sep 09; Vol. 59 (17), pp. 2302-2319.e12. Date of Electronic Publication: 2024 Jun 03.
Autor:
Gotoh O; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Sugiyama Y; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan.; Division of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Japan., Tonooka A; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Japan., Kosugi M; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Kitaura S; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Minegishi R; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Sano M; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Amino S; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Furuya R; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Tanaka N; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Kaneyasu T; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Kumegawa K; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Japan., Abe A; Division of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Japan., Nomura H; Division of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Japan., Takazawa Y; Department of Pathology, Toranomon Hospital, Minato-ku, Japan., Kanao H; Division of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Japan., Maruyama R; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Japan., Noda T; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan., Mori S; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan.; Department of Genetic Diagnosis, Cancer Institute Hospital, JFCR, Koto-ku, Japan.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Jul; Vol. 263 (3), pp. 275-287. Date of Electronic Publication: 2024 May 11.
Autor:
Yang L; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. kohei.kumegawa@jfcr.or.jp., Saeki S; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Nakadai T; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2024 May; Vol. 31 (5), pp. 736-745. Date of Electronic Publication: 2024 Mar 01.
Autor:
Inoue F; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Sone K; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT‑Ganken Program, Japanese Foundation for Cancer Research, Tokyo 135‑8550, Japan., Hachijo R; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Suzuki E; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Tanimoto S; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Tsuboyama N; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Kato K; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Toyohara Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Takahashi Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Kusakabe M; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Kukita A; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Honjoh H; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Nishijima A; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Taguchi A; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Miyamoto Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Tanikawa M; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Iriyama T; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Mori M; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Wada-Hiraike O; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Oda K; Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan., Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060‑8556, Japan., Maruyama R; Cancer Cell Diversity Project, NEXT‑Ganken Program, Japanese Foundation for Cancer Research, Tokyo 135‑8550, Japan., Osuga Y; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113‑8655, Japan.
Publikováno v:
International journal of oncology [Int J Oncol] 2024 Mar; Vol. 64 (3). Date of Electronic Publication: 2024 Feb 01.
Autor:
Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Saeki S; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Takahashi Y; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Yang L; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Osako T; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Nakadai T; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Amino S; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Maeda T; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Takahata C; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Mori S; Project for Development of Innovative Research on Cancer Therapeutics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Noda T; Director's room, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Ohno S; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Ueno T; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Mar; Vol. 128 (7), pp. 1208-1222. Date of Electronic Publication: 2023 Feb 01.
Publikováno v:
Clinical Ophthalmology, Vol 2015, Iss default, Pp 1491-1498 (2015)
Noriko Kato,1,2 Genichiro Takahashi,1,2 Koichi Kumegawa,1,2 Yoshiaki Kabata,1,2 Hiroshi Tsuneoka1 1Department of Ophthalmology, Jikei University, School of Medicine, 2Katsushika Medical Center, Tokyo, Japan Background: We investigated indications and
Externí odkaz:
https://doaj.org/article/18d96634b585444cb1f8cd26cde1c885
Autor:
Yi JM; Department of Microbiology and Immunology, College of Medicine, Inje University, Busan, South Korea., Kang TH; Department of Biological Science, Dong-A University, Busan, South Korea., Han YK; Department of Microbiology and Immunology, College of Medicine, Inje University, Busan, South Korea., Park HY; Department of Pathology, College of Medicine, Inje University, Busan, South Korea., Yang JH; Department of Physiology and Convergence Medical Science, Institute of Health Sciences, Gyeongsang National University Medical School, Jinju, South Korea., Bae JH; Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan, South Korea., Suh JS; Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan, South Korea., Kim TJ; Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan, South Korea., Kim JG; Research Center, Dongnam Institute of Radiological and Medical Sciences, Busan, South Korea., Cui YH; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, South Korea.; Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL, USA., Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Kim SJ; Department of Pathology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, South Korea., Zhao Y; Institute for Translation Medicine, Qingdao University, Qingdao, China., Park IJ; Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Hong SM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Chung JY; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lee SJ; Fibrosis & Cancer Targeting Biotechnology, Seoul, South Korea.
Publikováno v:
EMBO reports [EMBO Rep] 2023 Aug 03; Vol. 24 (8), pp. e56335. Date of Electronic Publication: 2023 Jun 21.
Autor:
Kitajima H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Maruyama R; Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Niinuma T; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Yamamoto E; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Takasawa A; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Takasawa K; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Ishiguro K; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Tsuyada A; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Suzuki R; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Sudo G; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Kubo T; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Mitsuhashi K; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Idogawa M; Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan., Tange S; Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan., Toyota M; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Yoshido A; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Kai M; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan., Yanagihara K; Division of Rare Cancer Research, National Cancer Center Research Institute, Tokyo, Japan., Tokino T; Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan., Osanai M; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Nakase H; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan., Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan. hsuzuki@sapmed.ac.jp.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Jul 13; Vol. 14 (7), pp. 424. Date of Electronic Publication: 2023 Jul 13.